MedTrace Logo

ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain

NCT03261193 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2024-05-06

Study results available
· View outcomes & findings →

Summary

Comparison of standard post-operative cesarean surgery pain management with regional post-op pain control.

Conditions

  • Pain, Postoperative

Interventions

DRUG

ITM + Sham QLB

Sham subcutaneous non-anesthetic infiltration with saline

DRUG

ITM + Bupivacaine QLB

QL plane block with local anesthesia

Sponsors & Collaborators

  • Nicholas Schott

    lead OTHER

Principal Investigators

  • Amy Monroe · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-05
Primary Completion
2018-06-25
Completion
2022-11-11
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03261193 on ClinicalTrials.gov